IL6 and Miyoshi myopathy: Human IL-6 transgenic mice (136) improved the implantation rate of MM, provided the niche key factor for MM growth in mice, and allowed the implantation of precancerous, malignant plasma cells and non-malignant cells, promoting the study of myoid-derived suppressor cells in MM immune mechanism.